Published in J Bacteriol on August 10, 2007
Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res (2009) 3.99
Efflux-mediated drug resistance in bacteria: an update. Drugs (2009) 3.18
Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog (2008) 2.71
LPS remodeling is an evolved survival strategy for bacteria. Proc Natl Acad Sci U S A (2012) 2.05
Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat Rev Microbiol (2013) 1.88
An ABC transport system that maintains lipid asymmetry in the gram-negative outer membrane. Proc Natl Acad Sci U S A (2009) 1.81
Outer Membrane Vesicle Production Facilitates LPS Remodeling and Outer Membrane Maintenance in Salmonella during Environmental Transitions. MBio (2016) 1.46
PhoPQ regulates acidic glycerophospholipid content of the Salmonella Typhimurium outer membrane. Proc Natl Acad Sci U S A (2014) 1.14
Elucidation of a novel Vibrio cholerae lipid A secondary hydroxy-acyltransferase and its role in innate immune recognition. Mol Microbiol (2011) 1.10
Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob Agents Chemother (2014) 1.10
Surface-localized spermidine protects the Pseudomonas aeruginosa outer membrane from antibiotic treatment and oxidative stress. J Bacteriol (2011) 1.07
Molecular mechanism for lateral lipid diffusion between the outer membrane external leaflet and a beta-barrel hydrocarbon ruler. Biochemistry (2009) 1.05
Adaptation and preadaptation of Salmonella enterica to Bile. PLoS Genet (2012) 1.03
An inner membrane dioxygenase that generates the 2-hydroxymyristate moiety of Salmonella lipid A. Biochemistry (2008) 1.03
Loss of elongation factor P disrupts bacterial outer membrane integrity. J Bacteriol (2011) 1.01
The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli. Mol Microbiol (2011) 0.99
Antimicrobial peptides activate the Rcs regulon through the outer membrane lipoprotein RcsF. J Bacteriol (2010) 0.99
Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae. PLoS Pathog (2012) 0.99
Microbial modulation of host immunity with the small molecule phosphorylcholine. Infect Immun (2012) 0.96
Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria? PLoS One (2008) 0.95
Hydroxylated ornithine lipids increase stress tolerance in Rhizobium tropici CIAT899. Mol Microbiol (2011) 0.92
Association of a protective monoclonal IgA with the O antigen of Salmonella enterica serovar Typhimurium impacts type 3 secretion and outer membrane integrity. Infect Immun (2012) 0.91
The effect of the potential PhoQ histidine kinase inhibitors on Shigella flexneri virulence. PLoS One (2011) 0.90
Roles of the outer membrane protein AsmA of Salmonella enterica in the control of marRAB expression and invasion of epithelial cells. J Bacteriol (2009) 0.90
In vitro evaluation of the potential for resistance development to ceragenin CSA-13. J Antimicrob Chemother (2012) 0.87
Effect of PhoP-PhoQ activation by broad repertoire of antimicrobial peptides on bacterial resistance. J Biol Chem (2011) 0.87
Differential regulation by magnesium of the two MsbB paralogs of Shigella flexneri. J Bacteriol (2008) 0.86
Complex transcriptional and post-transcriptional regulation of an enzyme for lipopolysaccharide modification. Mol Microbiol (2013) 0.86
New antibiotic molecules: bypassing the membrane barrier of gram negative bacteria increases the activity of peptide deformylase inhibitors. PLoS One (2009) 0.86
Bacterial mechanosensitive channels: progress towards an understanding of their roles in cell physiology. Curr Opin Microbiol (2014) 0.86
Accumulation of phosphatidic acid increases vancomycin resistance in Escherichia coli. J Bacteriol (2014) 0.85
Virulence and stress-related periplasmic protein (VisP) in bacterial/host associations. Proc Natl Acad Sci U S A (2013) 0.83
Deciphering the acylation pattern of Yersinia enterocolitica lipid A. PLoS Pathog (2012) 0.82
Agrobacteria lacking ornithine lipids induce more rapid tumour formation. Environ Microbiol (2012) 0.82
Characterization of Pseudomonas aeruginosa LpxT reveals dual positional lipid A kinase activity and co-ordinated control of outer membrane modification. Mol Microbiol (2014) 0.82
PmrD is required for modifications to escherichia coli endotoxin that promote antimicrobial resistance. Antimicrob Agents Chemother (2015) 0.82
Absence of PmrAB-mediated phosphoethanolamine modifications of Citrobacter rodentium lipopolysaccharide affects outer membrane integrity. J Bacteriol (2011) 0.81
Deciphering tissue-induced Klebsiella pneumoniae lipid A structure. Proc Natl Acad Sci U S A (2015) 0.81
Dam methylation controls O-antigen chain length in Salmonella enterica serovar enteritidis by regulating the expression of Wzz protein. J Bacteriol (2009) 0.81
Codependent and independent effects of nitric oxide-mediated suppression of PhoPQ and Salmonella pathogenicity island 2 on intracellular Salmonella enterica serovar typhimurium survival. Infect Immun (2009) 0.81
Tissue repair in myxobacteria: A cooperative strategy to heal cellular damage. Bioessays (2016) 0.80
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It. ACS Infect Dis (2016) 0.80
Latency of the lipid A deacylase PagL is involved in producing a robust permeation barrier in the outer membrane of Salmonella enterica. J Bacteriol (2010) 0.79
Disruption of an M. tuberculosis membrane protein causes a magnesium-dependent cell division defect and failure to persist in mice. PLoS Pathog (2015) 0.78
Inscribing the perimeter of the PagP hydrocarbon ruler by site-specific chemical alkylation. Biochemistry (2010) 0.78
Dam methylation participates in the regulation of PmrA/PmrB and RcsC/RcsD/RcsB two component regulatory systems in Salmonella enterica serovar Enteritidis. PLoS One (2013) 0.78
Identification of EnvC and Its Cognate Amidases as Novel Determinants of Intrinsic Resistance to Cationic Antimicrobial Peptides. Antimicrob Agents Chemother (2016) 0.78
Endotoxin structures in the psychrophiles Psychromonas marina and Psychrobacter cryohalolentis contain distinctive acyl features. Mar Drugs (2014) 0.77
New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides. Antimicrob Agents Chemother (2014) 0.76
Site-specific activity of the acyltransferases HtrB1 and HtrB2 in Pseudomonas aeruginosa lipid A biosynthesis. Pathog Dis (2015) 0.76
Short, Synthetic Cationic Peptides Have Antibacterial Activity against Mycobacterium smegmatis by Forming Pores in Membrane and Synergizing with Antibiotics. Antibiotics (Basel) (2015) 0.76
D-form KLKLLLLLKLK-NH2 peptide exerts higher antimicrobial properties than its L-form counterpart via an association with bacterial cell wall components. Sci Rep (2017) 0.75
Modification of Salmonella Lipopolysaccharides Prevents the Outer Membrane Penetration of Novobiocin. Biophys J (2015) 0.75
Motuporamine Derivatives as Antimicrobial Agents and Antibiotic Enhancers against Resistant Gram-Negative Bacteria. Chembiochem (2017) 0.75
Polymorphic Regulation of Outer Membrane Lipid A Composition. MBio (2016) 0.75
Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii. BMC Microbiol (2016) 0.75
Stenotrophomonas maltophilia PhoP, a Two-Component Response Regulator, Involved in Antimicrobial Susceptibilities. PLoS One (2016) 0.75
Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev (2003) 13.49
Crystal structures explain functional properties of two E. coli porins. Nature (1992) 10.38
Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60
An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci U S A (1973) 8.45
Agents that increase the permeability of the outer membrane. Microbiol Rev (1992) 7.52
Protein composition of the outer membrane of Salmonella typhimurium: effect of lipopolysaccharide mutations. J Bacteriol (1974) 7.07
Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol (1993) 6.24
Positive selection vectors for allelic exchange. Gene (1996) 5.97
Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J Bacteriol (1996) 5.58
PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol (1998) 5.01
Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science (1997) 4.81
Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell (2005) 4.78
Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell (1998) 4.42
Efflux-mediated drug resistance in bacteria. Drugs (2004) 3.90
The proton motive force in bacteria: a critical assessment of methods. Annu Rev Microbiol (1985) 3.76
Spectrofluorometric studies of the lipid probe, nile red. J Lipid Res (1985) 3.25
Outer membrane of Salmonella typhimurium: accessibility of phospholipid head groups to phospholipase c and cyanogen bromide activated dextran in the external medium. Biochemistry (1976) 2.88
Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J Bacteriol (2001) 2.63
Characterization of the micro-environment of Salmonella typhimurium-containing vacuoles within MDCK epithelial cells. Mol Microbiol (1992) 2.34
Outer membranes of gram-negative bacteria are permeable to steroid probes. Mol Microbiol (1992) 2.32
Regulation of polymyxin resistance and adaptation to low-Mg2+ environments. J Bacteriol (1997) 2.29
Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells. J Antimicrob Chemother (1981) 2.29
A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol (2000) 2.26
Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol (2003) 2.01
Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol Microbiol (1995) 1.94
Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect (2001) 1.91
Oxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, A new Fe2+/alpha-ketoglutarate-dependent dioxygenase homologue. J Biol Chem (2000) 1.76
3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J Biol Chem (2004) 1.67
Metal bridges between the PhoQ sensor domain and the membrane regulate transmembrane signaling. J Mol Biol (2005) 1.61
Lipid trafficking controls endotoxin acylation in outer membranes of Escherichia coli. J Biol Chem (2004) 1.50
The lipid A palmitoyltransferase PagP: molecular mechanisms and role in bacterial pathogenesis. Mol Microbiol (2005) 1.49
Identification of cptA, a PmrA-regulated locus required for phosphoethanolamine modification of the Salmonella enterica serovar typhimurium lipopolysaccharide core. J Bacteriol (2005) 1.46
Role of Mg2+ and pH in the modification of Salmonella lipid A after endocytosis by macrophage tumour cells. Mol Microbiol (2005) 1.41
Visualization of vacuolar acidification-induced transcription of genes of pathogens inside macrophages. Mol Biol Cell (2005) 1.37
Resistance to the antimicrobial peptide polymyxin requires myristoylation of Escherichia coli and Salmonella typhimurium lipid A. J Biol Chem (2005) 1.35
Extragenic suppressors of growth defects in msbB Salmonella. J Bacteriol (2001) 1.31
The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics. Biochemistry (2000) 1.21
The PmrA/PmrB and RcsC/YojN/RcsB systems control expression of the Salmonella O-antigen chain length determinant. Mol Microbiol (2006) 1.10
pmrA(Con) confers pmrHFIJKL-dependent EGTA and polymyxin resistance on msbB Salmonella by decorating lipid A with phosphoethanolamine. J Bacteriol (2007) 1.04
Mammalian steroid hormones are substrates for the major RND- and MFS-type tripartite multidrug efflux pumps of Escherichia coli. J Bacteriol (2006) 0.98
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol (2006) 9.64
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A (2006) 8.85
Salmonellae interplay with host cells. Nat Rev Microbiol (2008) 5.26
Aminoglycoside antibiotics induce bacterial biofilm formation. Nature (2005) 4.93
Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell (2005) 4.78
Efflux-mediated drug resistance in bacteria. Drugs (2004) 3.90
Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science (2003) 3.64
Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol (2002) 3.56
Efflux-mediated drug resistance in bacteria: an update. Drugs (2009) 3.18
Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J Bacteriol (2002) 2.98
Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol (2007) 2.87
PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J Bacteriol (2004) 2.80
Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains. Genome Biol (2007) 2.68
Cyclic di-GMP as a bacterial second messenger. Microbiology (2004) 2.54
The baeSR two-component regulatory system activates transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and increases its resistance to novobiocin and deoxycholate. J Bacteriol (2002) 2.46
A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study. J Bacteriol (2005) 2.35
Variation in lipid A structure in the pathogenic yersiniae. Mol Microbiol (2004) 2.28
Structure and function of Salmonella SifA indicate that its interactions with SKIP, SseJ, and RhoA family GTPases induce endosomal tubulation. Cell Host Microbe (2008) 2.21
Structural characterization of the molecular platform for type III secretion system assembly. Nature (2005) 2.20
Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am J Physiol Lung Cell Mol Physiol (2004) 2.19
Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol Microbiol (2003) 2.18
Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect Immun (2006) 2.18
Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence. Infect Immun (2009) 2.07
Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol (2011) 2.03
A conserved structural motif mediates formation of the periplasmic rings in the type III secretion system. Nat Struct Mol Biol (2009) 2.02
Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol (2003) 2.01
Asymmetrical distribution of the second messenger c-di-GMP upon bacterial cell division. Science (2010) 1.99
Activation of the bacterial sensor kinase PhoQ by acidic pH. Mol Cell (2007) 1.98
Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean. Anal Chem (2009) 1.96
Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2006) 1.95
Type IV pili-mediated secretion modulates Francisella virulence. Mol Microbiol (2006) 1.83
Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J Bacteriol (2005) 1.78
Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. Inflamm Bowel Dis (2015) 1.74
Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros (2008) 1.71
Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ Microbiol (2003) 1.68
3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J Biol Chem (2004) 1.67
Conformation of the AcrB multidrug efflux pump in mutants of the putative proton relay pathway. J Bacteriol (2006) 1.66
Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes. Am J Respir Crit Care Med (2014) 1.66
Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother (2004) 1.63
AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity. J Bacteriol (2003) 1.62
Metal bridges between the PhoQ sensor domain and the membrane regulate transmembrane signaling. J Mol Biol (2005) 1.61
Characterization of protein cross-links via mass spectrometry and an open-modification search strategy. Anal Chem (2008) 1.56
Salmonella effectors translocated across the vacuolar membrane interact with the actin cytoskeleton. Mol Microbiol (2003) 1.55
Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison. Infect Immun (2006) 1.55
Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A (2009) 1.55
Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A (2010) 1.54
Role of the Salmonella pathogenicity island 1 (SPI-1) protein InvB in type III secretion of SopE and SopE2, two Salmonella effector proteins encoded outside of SPI-1. J Bacteriol (2003) 1.54
Chimeric analysis of AcrA function reveals the importance of its C-terminal domain in its interaction with the AcrB multidrug efflux pump. J Bacteriol (2003) 1.53
Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei. Infect Immun (2008) 1.52
Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog (2010) 1.50
Export of autotransported proteins proceeds through an oligomeric ring shaped by C-terminal domains. EMBO J (2002) 1.50
The Salmonella enterica serovar typhimurium translocated effectors SseJ and SifB are targeted to the Salmonella-containing vacuole. Infect Immun (2003) 1.49
MglA and Igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages. Infect Immun (2008) 1.49
The Salmonellae PhoQ sensor: mechanisms of detection of phagosome signals. Cell Microbiol (2008) 1.49
Differentiation and distribution of colistin- and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms. J Bacteriol (2006) 1.46
Structural analysis of the essential self-cleaving type III secretion proteins EscU and SpaS. Nature (2008) 1.45
Covalently linked trimer of the AcrB multidrug efflux pump provides support for the functional rotating mechanism. J Bacteriol (2008) 1.45
Genome-specific gas-phase fractionation strategy for improved shotgun proteomic profiling of proteotypic peptides. Anal Chem (2008) 1.44
The bacterial second messenger c-di-GMP: mechanisms of signalling. Cell Microbiol (2011) 1.44
Evolution of Burkholderia pseudomallei in recurrent melioidosis. PLoS One (2012) 1.43
The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. J Bacteriol (2006) 1.43
Assembly of the type III secretion needle complex of Salmonella typhimurium. Microbes Infect (2002) 1.41
The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol (2012) 1.40
Site-directed disulfide cross-linking shows that cleft flexibility in the periplasmic domain is needed for the multidrug efflux pump AcrB of Escherichia coli. J Bacteriol (2007) 1.39
An inhibitor of gram-negative bacterial virulence protein secretion. Cell Host Microbe (2008) 1.39
Quantitative proteomic analysis indicates increased synthesis of a quinolone by Pseudomonas aeruginosa isolates from cystic fibrosis airways. Proc Natl Acad Sci U S A (2003) 1.39
Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation. J Bacteriol (2006) 1.34
PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother (2011) 1.33
Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections. PLoS One (2013) 1.33
PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother (2011) 1.32
Threonine-978 in the transmembrane segment of the multidrug efflux pump AcrB of Escherichia coli is crucial for drug transport as a probable component of the proton relay network. J Bacteriol (2006) 1.31
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates. Antimicrob Agents Chemother (2010) 1.30
SseJ deacylase activity by Salmonella enterica serovar Typhimurium promotes virulence in mice. Infect Immun (2005) 1.30
Kinetic parameters of efflux of penicillins by the multidrug efflux transporter AcrAB-TolC of Escherichia coli. Antimicrob Agents Chemother (2010) 1.30
A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1. Cell Microbiol (2006) 1.27
Functional genetic screen of human diversity reveals that a methionine salvage enzyme regulates inflammatory cell death. Proc Natl Acad Sci U S A (2012) 1.26
SpiC is required for translocation of Salmonella pathogenicity island 2 effectors and secretion of translocon proteins SseB and SseC. J Bacteriol (2002) 1.26
Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations. Proc Natl Acad Sci U S A (2012) 1.25
Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob Agents Chemother (2003) 1.25
A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. Infect Immun (2003) 1.25
Substrate path in the AcrB multidrug efflux pump of Escherichia coli. Mol Microbiol (2010) 1.24
Pseudomonas aeruginosa porin OprF exists in two different conformations. J Biol Chem (2006) 1.22
Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J Bacteriol (2007) 1.21
Identification of an unconventional E3 binding surface on the UbcH5 ~ Ub conjugate recognized by a pathogenic bacterial E3 ligase. Proc Natl Acad Sci U S A (2010) 1.20
The response threshold of Salmonella PilZ domain proteins is determined by their binding affinities for c-di-GMP. Mol Microbiol (2012) 1.19
Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. J Infect Dis (2007) 1.19
A genome-wide in vitro bacterial-infection screen reveals human variation in the host response associated with inflammatory disease. Am J Hum Genet (2009) 1.18
Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis. Clin Vaccine Immunol (2013) 1.17
mig-14 is a Salmonella gene that plays a role in bacterial resistance to antimicrobial peptides. J Bacteriol (2002) 1.16
Large-insert genome analysis technology detects structural variation in Pseudomonas aeruginosa clinical strains from cystic fibrosis patients. Genomics (2008) 1.14
PhoPQ regulates acidic glycerophospholipid content of the Salmonella Typhimurium outer membrane. Proc Natl Acad Sci U S A (2014) 1.14
Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica. PLoS Pathog (2012) 1.13
Substituted 2-imino-5-arylidenethiazolidin-4-one inhibitors of bacterial type III secretion. J Med Chem (2008) 1.13
Transcription of the SsrAB regulon is repressed by alkaline pH and is independent of PhoPQ and magnesium concentration. J Bacteriol (2002) 1.12
Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4. J Endotoxin Res (2003) 1.11
Salmonella-induced filament formation is a dynamic phenotype induced by rapidly replicating Salmonella enterica serovar typhimurium in epithelial cells. Infect Immun (2005) 1.10
OmpA is the principal nonspecific slow porin of Acinetobacter baumannii. J Bacteriol (2012) 1.09